Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | JZP815 |
Synonyms | |
Therapy Description |
JZP815 is a pan-Raf inhibitor, which potentially inhibits Mapk signaling and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2677). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
JZP815 | JZP 815|JZP-815 | RAF Inhibitor (Pan) 27 | JZP815 is a pan-Raf inhibitor, which potentially inhibits Mapk signaling and tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2677). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05557045 | Phase I | JZP815 | A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815 | Recruiting | USA | 0 |